GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Accounts Payable

Acticor Biotech (XPAR:ALACT) Accounts Payable : €5.27 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Accounts Payable?

Acticor Biotech's Accounts Payable for the quarter that ended in Jun. 2023 was €5.27 Mil.

Acticor Biotech's quarterly Accounts Payable increased from Jun. 2022 (€3.26 Mil) to Dec. 2022 (€5.14 Mil) and increased from Dec. 2022 (€5.14 Mil) to Jun. 2023 (€5.27 Mil).

Acticor Biotech's annual Accounts Payable increased from Dec. 2020 (€2.72 Mil) to Dec. 2021 (€3.03 Mil) and increased from Dec. 2021 (€3.03 Mil) to Dec. 2022 (€5.14 Mil).


Acticor Biotech Accounts Payable Historical Data

The historical data trend for Acticor Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Accounts Payable Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accounts Payable
Get a 7-Day Free Trial 0.51 1.62 2.72 3.03 5.14

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Accounts Payable Get a 7-Day Free Trial Premium Member Only 3.33 3.03 3.26 5.14 5.27

Acticor Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Acticor Biotech Accounts Payable Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines